Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia

Erstveröffentlichung
2021Authors
DiNardo, Courtney D.
Stein, Anthony S.
Stein, Eytan M.
Fathi, Amir T.
Frankfurt, Olga
Wissenschaftlicher Artikel
Published in
Journal of Clinical Oncology ; 39 (2021), 1. - S. 57-65. - ISSN 0732-183X. - eISSN 1527-7755
Link to publication
https://dx.doi.org/10.1200/JCO.20.01632Institutions
UKU. Klinik für Innere Medizin IIISubject headings
[Free subject headings]: ONCOMETABOLITE 2-HYDROXYGLUTARATE | IDH2 MUTATIONS | OLDER PATIENTS | RESISTANCE | PROGNOSIS | CARE[DDC subject group]: DDC 610 / Medicine & health